PULMATRIX, INC. Investing Cash Flow
PULMATRIX, INC. (PULM) reported Investing Cash Flow of -$398.00 thousand for the 12-month period ending 2024-12-31, per its S-4/A filed 2026-09-17.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-09-17
- PULMATRIX, INC. net cash provided by (used in) investing activities for the quarter ending 2024-12-31 was $0.00.
- PULMATRIX, INC. net cash provided by (used in) investing activities for the quarter ending 2024-09-30 was $0.00.
- PULMATRIX, INC. net cash provided by (used in) investing activities for the quarter ending 2024-06-30 was -$244.00K.
- PULMATRIX, INC. net cash provided by (used in) investing activities for the quarter ending 2024-03-31 was -$154.00K.
- PULMATRIX, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$676.00K.
- PULMATRIX, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$86.00K.
- PULMATRIX, INC. net cash provided by (used in) investing activities for fiscal 2021 was -$144.00K.
- PULMATRIX, INC. net cash provided by (used in) investing activities for fiscal 2020 was -$281.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: S-4/A 12 month − 10-Q 9 month · filed 2026-09-17 | $0.00 derived: sum of 2 quarters · filed 2026-09-17 | -$244.00K derived: sum of 3 quarters · filed 2026-09-17 | -$398.00K S-4/A · filed 2026-09-17 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-16 | -$244.00K derived: sum of 2 quarters · filed 2025-10-16 | -$398.00K 10-Q · filed 2025-10-16 | -$703.00K derived: sum of 4 quarters · filed 2025-10-16 |
| 2024-06-30 | -$244.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$398.00K 10-Q · filed 2025-08-06 | -$703.00K derived: sum of 3 quarters · filed 2025-08-06 | -$1.02M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$154.00K 10-Q · filed 2025-05-15 | -$459.00K derived: sum of 2 quarters · filed 2025-05-15 | -$772.00K derived: sum of 3 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$305.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$618.00K derived: sum of 2 quarters · filed 2025-03-21 | -$676.00K 10-K · filed 2025-03-21 | |
| 2023-09-30 | -$313.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$371.00K 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | -$58.00K 10-Q · filed 2024-08-13 | |||
| 2022-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$9.00K derived: sum of 2 quarters · filed 2024-03-28 | -$76.00K derived: sum of 3 quarters · filed 2024-03-28 | -$86.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$67.00K derived: sum of 2 quarters · filed 2023-11-09 | -$77.00K 10-Q · filed 2023-11-09 | -$103.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$77.00K 10-Q · filed 2023-08-10 | -$103.00K derived: sum of 3 quarters · filed 2023-08-10 | -$203.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$10.00K 10-Q · filed 2023-05-12 | -$36.00K derived: sum of 2 quarters · filed 2023-05-12 | -$136.00K derived: sum of 3 quarters · filed 2023-05-12 | |
| 2021-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$126.00K derived: sum of 2 quarters · filed 2023-03-30 | -$144.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$118.00K 10-Q · filed 2022-11-10 | ||
| 2021-06-30 | -$18.00K 10-Q · filed 2022-08-10 | |||
| 2020-12-31 | -$83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$183.00K derived: sum of 2 quarters · filed 2022-03-29 | -$185.00K derived: sum of 3 quarters · filed 2022-03-29 | -$281.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$102.00K derived: sum of 2 quarters · filed 2021-11-10 | -$198.00K 10-Q · filed 2021-11-10 | -$207.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$98.00K 10-Q · filed 2021-08-10 | -$107.00K derived: sum of 3 quarters · filed 2021-08-10 | -$121.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$96.00K 10-Q · filed 2021-05-11 | -$105.00K derived: sum of 2 quarters · filed 2021-05-11 | -$119.00K derived: sum of 3 quarters · filed 2021-05-11 | -$144.00K derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | -$23.00K derived: sum of 2 quarters · filed 2021-03-23 | -$48.00K derived: sum of 3 quarters · filed 2021-03-23 | -$58.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | -$14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$39.00K derived: sum of 2 quarters · filed 2020-11-12 | -$49.00K 10-Q · filed 2020-11-12 | -$60.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$35.00K 10-Q · filed 2020-08-07 | -$46.00K derived: sum of 3 quarters · filed 2020-08-07 | -$52.00K derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | -$10.00K 10-Q · filed 2020-05-14 | -$21.00K derived: sum of 2 quarters · filed 2020-05-14 | -$27.00K derived: sum of 3 quarters · filed 2020-05-14 | |
| 2018-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$17.00K derived: sum of 2 quarters · filed 2020-03-26 | -$19.00K 10-K · filed 2020-03-26 | |
| 2018-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | -$8.00K 10-Q · filed 2019-11-01 | ||
| 2018-06-30 | -$2.00K 10-Q · filed 2019-08-05 | |||
| 2017-12-31 | -$38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | -$61.00K derived: sum of 2 quarters · filed 2019-02-19 | -$74.00K 10-K · filed 2019-02-19 | |
| 2017-09-30 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$36.00K 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | -$13.00K 10-Q · filed 2018-08-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |